Beresford C H, Palmer J, Kenny M W
Scand J Haematol Suppl. 1977;32:175-82. doi: 10.1111/j.1600-0609.1977.tb01233.x.
An iron-poly (sorbitol-gluconic acid) complex (Ferastral) labelled with 59Fe was administered by intramuscular injection to clinically and haematologically normal male volunteers. Urinary excretion of radioactivity was measured for the first 48 hours following injection, and was 2%-10% of the administered dose. Disappearance of radioactivity at the site of injection and accumulation of radioactivity in the liver, spleen, and sacrum were measured by external scintillation counting. Plasma radioactivity was measured at intervals for four days and red cell incorporation of 59Fe reached levels of 29%-57.5%. An unexpected finding was that the highest levels of urinary excretion of radioactivity did not coincide with the highest levels of plasma radioactivity.
用59Fe标记的铁-聚(山梨醇-葡萄糖酸)复合物(Ferastral)通过肌肉注射给予临床和血液学检查正常的男性志愿者。在注射后的头48小时测量尿液放射性排泄量,其为给药剂量的2%-10%。通过外部闪烁计数测量注射部位放射性的消失以及肝脏、脾脏和骶骨中放射性的积累。每隔一段时间测量血浆放射性,59Fe在红细胞中的掺入水平达到29%-57.5%。一个意外发现是,尿液放射性排泄的最高水平与血浆放射性的最高水平并不一致。